Creo Medical (GB:CREO) has released an update.
Creo Medical Group PLC announced it has successfully raised approximately £12 million through a share placement of 50,000,000 shares at 24 pence each, with net proceeds expected to be around £11 million. The funds will support the ongoing development of Creo’s technology and mitigate risks associated with the divestment of a majority stake in Creo Europe. The company has received strong backing from existing shareholders, including directors of the company who have also invested in the placement.
For further insights into GB:CREO stock, check out TipRanks’ Stock Analysis page.
